These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10334013)

  • 21. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
    Akkuzu B; Ozgirgin N; Ozlüoğlu LN
    Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Meniere's disease. The clinical effect of gentamicin treatment].
    Kjaer D; Pedersen CB
    Ugeskr Laeger; 2000 May; 162(19):2739-43. PubMed ID: 10827541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intratympanic gentamicin for Ménière's disease: effect on quality of life as assessed by Glasgow benefit inventory.
    Banerjee AS; Johnson IJ
    J Laryngol Otol; 2006 Oct; 120(10):827-31. PubMed ID: 16707038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low dose transtympanic gentamicin treatment for intractable Meniere's disease: a prospective study.
    Kasemsuwan L; Jariengprasert C; Ruencharopen S; Orathai P
    J Med Assoc Thai; 2007 Feb; 90(2):327-34. PubMed ID: 17375639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vestibular function at the end of intratympanic gentamicin treatment of patients with Ménière's disease.
    Perez N; Rama-Lopez J
    J Vestib Res; 2005; 15(1):49-58. PubMed ID: 15908740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intratympanic gentamicin for the treatment of unilateral Meniere's disease.
    Kaplan DM; Nedzelski JM; Chen JM; Shipp DB
    Laryngoscope; 2000 Aug; 110(8):1298-305. PubMed ID: 10942130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intratympanic gentamicin: a 1-day protocol treatment for unilateral Meniere's disease.
    De Stefano A; Dispenza F; De Donato G; Caruso A; Taibah A; Sanna M
    Am J Otolaryngol; 2007; 28(5):289-93. PubMed ID: 17826528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose intratympanic gentamicin treatment for dizziness in Ménière's disease.
    Longridge NS; Mallinson AI
    J Otolaryngol; 2000 Feb; 29(1):35-9. PubMed ID: 10709170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disability in patients with Menière's disease following the use of two different treatment modalities: betahistine and intratympanic gentamicin.
    Enrique-Gonzaleza A; Sánchez-Ferrándiz N; Pérez-Fernández N
    Rev Laryngol Otol Rhinol (Bord); 2008; 129(4-5):249-54. PubMed ID: 19408504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benign paroxysmal positional vertigo in patients with Ménière's disease treated with intratympanic gentamycin.
    Perez N; Martin E; Zubieta JL; Romero MD; Garcia-Tapia R
    Laryngoscope; 2002 Jun; 112(6):1104-9. PubMed ID: 12160282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of Ménière's disease by intratympanic gentamicin application.
    Assimakopoulos D; Patrikakos G
    J Laryngol Otol; 2003 Jan; 117(1):10-6. PubMed ID: 12590850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA; Chen DA; Arriaga MA
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transtympanic gentamicin treatment in Meniere's disease: a preliminary report.
    Kasemsuwan L; Jariengprasert C; Chaturapatranont S
    J Med Assoc Thai; 2006 Jul; 89(7):979-85. PubMed ID: 16881430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gentamicin injections for Ménière disease: comparison of subjective and objective end points.
    Steenerson RL; Hardin RB; Cronin GW
    Ear Nose Throat J; 2008 Aug; 87(8):452-6. PubMed ID: 18712693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meniett therapy: rescue treatment in severe drug-resistant Ménière's disease?
    Boudewyns AN; Wuyts FL; Hoppenbrouwers M; Ketelslagers K; Vanspauwen R; Forton G; Van de Heyning PH
    Acta Otolaryngol; 2005 Dec; 125(12):1283-9. PubMed ID: 16303675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Curative effect of transtympanic perfusion of gentamicin on unilateral Ménière's disease].
    Nie GH; Lu YD
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1356-8. PubMed ID: 12930695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intratympanic gentamicin therapy for control of vertigo in unilateral Menire's disease: a prospective, double-blind, randomized, placebo-controlled trial.
    Postema RJ; Kingma CM; Wit HP; Albers FW; Van Der Laan BF
    Acta Otolaryngol; 2008 Aug; 128(8):876-80. PubMed ID: 18607963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
    Kaplan DM; Hehar SS; Bance ML; Rutka JA
    Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous intratympanic infusion of gentamicin via a microcatheter in Menière's disease.
    Schoendorf J; Neugebauer P; Michel O
    Otolaryngol Head Neck Surg; 2001 Feb; 124(2):203-7. PubMed ID: 11226958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intratympanic application of an antiviral agent for the treatment of Ménière's disease.
    Guyot JP; Maire R; Delaspre O
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(1):21-6; discussion 26-7. PubMed ID: 18235202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.